医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
11期
167-168
,共2页
康昆%翁感%俞锡川%夏立%张瑾%吴祯
康昆%翁感%俞錫川%夏立%張瑾%吳禎
강곤%옹감%유석천%하립%장근%오정
高血压%药物疗法%缬氨酸%心室功能
高血壓%藥物療法%纈氨痠%心室功能
고혈압%약물요법%힐안산%심실공능
Hypertension%drug therapy%Valine%Ventricular function
目的::探讨缬沙坦治疗对高血压患者左室舒张功能的影响。方法:60例左室舒张功能减低( E/A<1.0)而收缩功能正常原发性高血压患者分别于缬沙坦治疗前和治疗12个月后行超声心动图、脉冲波组织多普勒成像及背向散射积分检查。结果:缬沙坦治疗后E/A 比值明显增高(P<0.01), E/Ea 比值显著降低( P<0.01),循环周期变化幅度(CV-IBS)明显增加(P<0.01)。结论:缬沙坦治疗可以改善左室舒张功能减低高血压患者的心脏功能。
目的::探討纈沙坦治療對高血壓患者左室舒張功能的影響。方法:60例左室舒張功能減低( E/A<1.0)而收縮功能正常原髮性高血壓患者分彆于纈沙坦治療前和治療12箇月後行超聲心動圖、脈遲波組織多普勒成像及揹嚮散射積分檢查。結果:纈沙坦治療後E/A 比值明顯增高(P<0.01), E/Ea 比值顯著降低( P<0.01),循環週期變化幅度(CV-IBS)明顯增加(P<0.01)。結論:纈沙坦治療可以改善左室舒張功能減低高血壓患者的心髒功能。
목적::탐토힐사탄치료대고혈압환자좌실서장공능적영향。방법:60례좌실서장공능감저( E/A<1.0)이수축공능정상원발성고혈압환자분별우힐사탄치료전화치료12개월후행초성심동도、맥충파조직다보륵성상급배향산사적분검사。결과:힐사탄치료후E/A 비치명현증고(P<0.01), E/Ea 비치현저강저( P<0.01),순배주기변화폭도(CV-IBS)명현증가(P<0.01)。결론:힐사탄치료가이개선좌실서장공능감저고혈압환자적심장공능。
Objective:To explore the influence of valsartan for cardiac function of patients with hypertension combined with diastolic function diminution of left ventricle. Methods: 60 patients with hypertension combined with diastolic function diminution( E/A<1.0) but systolic function normal of left ventricle were examined by ultrasound cardiogram、p ulse tissue doppler imaging and integral of backscatter before the treatment with valsartan and after the treatment for twelve months.Results:T he E/A and CV-IBS increased obviously(P <0.01)and the E/Ea decreased obviously(P<0.01) after the treatment with valsartan. Conclusion: Valsartan can improve cardiac function of patients with hypertension combined with diastolic function diminution of left ventricle.